Description
Sotorasib is a inhibitor of KRASG12C, which is a notoriously difficult to treat cancerous mutation.
Product Unit Size | Cost | Quantity | Stock |
---|
Sotorasib is a inhibitor of KRASG12C, which is a notoriously difficult to treat cancerous mutation.
Cas No. | 2252403-56-6 |
---|---|
Purity | ≥99% |
Formula | C30H30F2N6O3 |
Formula Wt. | 560.61 |
IUPAC Name | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one |
Synonym | AMG-510 racemate |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zheng X, Luo J, Liu W, et al. Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12c mutation. Drugs Today (Barc). 2022 Apr;58(4):175-185. PMID: 35412531
Werner J, Davies R, Wahlstrom J, et al. Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12c, are associated with renal toxicity in the Sprague Dawley rat. Toxicol Appl Pharmacol. 2021 Jul 15;423:115578. PMID: 34004237
Koga T, Suda K, Fujino T, et al. KRAS secondary mutations that confer acquired resistance to KRAS G12c inhibitors, sotorasib and adagrasib, and overcoming strategies: insights from in vitro experiments. J Thorac Oncol. 2021 Aug;16(8):1321-1332. PMID: 33971321
Chloroethylnitrosourea, DNA alkylator and cross...
Recombinant HIV glycoprotein antigen fragment.<...
Endogenous catecholamine precursor, also found ...
Peptide, GLP-1 analog found in Heloderma; GLP-1...
Aminoglycoside; protein translation inhibitor.<...
DPP4 inhibitor.
Hydroxycinnamic acid found in various plant sou...
Steroid; AR antagonist.
Selective inhibitor of c-Met.
ERK2 inhibitor, potential AurKA, GSK3, CDK2, FL...
Triazolothienodiazepine; BRD inhibitor.
Endogenous hormone and neurotransmitter involve...
5-HT3 antagonist.
Calcium channel blocker.
EGFR inhibitor.
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
STING inhibitor
SIRT inhibitor.
PLK1 inhibitor.
β2-adrenergic agonist.